ITHS Small Pilot grant enables feasibility study

Elahe A Mostaghel, M.D., Ph.D successfully proposed a pilot project to establish the feasibility of using a metabolomic approach in patients undergoing testosterone suppression to identify a blood-based metabolic profile of the tissue response to androgen suppression, as well as a metabolic profile indicative of increased cardiovascular risk.

Dr. Mostaghel is an Assistant Member at the FHCRC and an Assistant Professor at the UW School of Medicine. She completed her residency in internal medicine at the University of California at San Francisco and a fellowship in medical oncology at the University of Washington. Clinically, she cares for patients with genitourinary cancers including prostate, bladder and testicular cancer.